Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

NEW YORK, Jan. 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

http://www.reportlinker.com/p0761163/Infectious-Immunology-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Summary

GlobalData's new report, "Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

- Market size data for Infectious Immunology market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology

- Annualized market revenues ($m) data for each of the segments and sub-segments within the five market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.

- 2011 company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Infectious Immunology market in BRICS.

- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Shanghai Kehua Bio-engineering Co., Ltd., Siemens Healthcare, bioMerieux S.A., DiaSorin S.p.A, Qiagen N.V., Transasia Bio-Medicals Ltd., Alere Inc., Beckman Coulter, Inc., Gen-Probe Incorporated, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Trivitron Healthcare Pvt Ltd., Span Diagnostics Ltd., Thermo Fisher Scientific Inc., Tulip Diagnostics (P) Ltd, Cellestis Limited, Chembio Diagnostics, Inc. and Hologic, Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Infectious Immunology competitive landscape in BRICS.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 11

2 Introduction 14

2.1 What is This Report About? 14

3 Infectious Immunology in BRICS 15

3.1 Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15

3.2 Infectious Immunology, BRICS, Company share (2010-2011) 21

4 Infectious Immunology In Brazil 23

4.1 Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23

4.2 Hepatitis Viruses In Brazi 29

4.2.1 Hepatitis Viruses, Brazil, Overall Revenue (2004-2018) 29

4.3 Other Virology In Brazil 31

4.3.1 Other Virology, Brazil, Overall Revenue (2004-2018) 31

4.4 Retroviruses In Brazil 33

4.4.1 Retroviruses, Brazil, Overall Revenue (2004-2018) 33

4.5 Bacteriology In Brazil 35

4.5.1 Bacteriology, Brazil, Overall Revenue (2004-2018) 35

4.6 Infectious Immunology Rapid Tests In Brazil 37

4.6.1 Infectious Immunology Rapid Tests, Brazil, Overall Revenue (2004-2018) 37

4.7 Infectious Immunology, Brazil, Distribution Share (2010-2011) 41

4.8 Infectious Immunology, Brazil, Company Share (2010-2011) 42

5 Infectious Immunology In Russian Federation 44

5.1 Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 44

5.2 Hepatitis Viruses In Russian Federation 50

5.2.1 Hepatitis Viruses, Russian Federation, Overall Revenue (2004-2018) 50

5.3 Retroviruses In Russian Federation 52

5.2.2 Retroviruses, Russian Federation, Overall Revenue (2004-2018) 52

5.3 Other Virology In Russian Federation 54

5.3.1 Other Virology, Russian Federation, Overall Revenue (2004-2018) 54

5.4 Bacteriology In Russian zFederation 56

5.4.1 Bacteriology, Russian Federation, Overall Revenue (2004-2018) 56

5.5 Infectious Immunology Rapid Tests In Russian Federation 58

5.5.1 Infectious Immunology Rapid Tests, Russian Federation, Overall Revenue (2004-2018) 58

5.6 Infectious Immunology, Russian Federation, Distribution Share (2010-2011) 62

5.7 Infectious Immunology, Russian Federation, Company Share (2010-2011) 63

6 Infectious Immunology In India 65

6.1 Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 65

6.2 Infectious Immunology Rapid Tests In India 71

6.2.1 Infectious Immunology Rapid Tests, India, Overall Revenue (2004-2018) 71

6.3 Hepatitis Viruses In India 75

6.3.1 Hepatitis Viruses, India, Overall Revenue (2004-2018) 75

6.4 Retroviruses In India 77

6.4.1 Retroviruses, India, Overall Revenue (2004-2018) 77

6.5 Bacteriology In India 79

6.5.1 Bacteriology, India, Overall Revenue (2004-2018) 79

6.6 Other Virology In India 81

6.6.1 Other Virology, India, Overall Revenue (2004-2018) 81

6.7 Infectious Immunology, India, Distribution Share (2010-2011) 83

6.8 Infectious Immunology, India, Company Share (2010-2011) 84

7 Infectious Immunology In China 86

7.1 Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 86

7.2 Retroviruses In China 92

7.2.1 Retroviruses, China, Overall Revenue (2004-2018) 92

7.3 Hepatitis Viruses In China 94

7.3.1 Hepatitis Viruses, China, Overall Revenue (2004-2018) 94

7.4 Other Virology In China 96

7.4.1 Other Virology, China, Overall Revenue (2004-2018) 96

7.5 Bacteriology In China 98

7.5.1 Bacteriology, China, Overall Revenue (2004-2018) 98

7.6 Infectious Immunology Rapid Tests In China 100

7.6.1 Infectious Immunology Rapid Tests, China, Overall Revenue (2004-2018) 100

7.7 Infectious Immunology, China, Distribution Share (2010-2011) 104

7.8 Infectious Immunology, China, Company Share (2010-2011) 105

8 Infectious Immunology In South Africa 107

8.1 Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107

8.2 Retroviruses In South Africa 113

8.2.1 Retroviruses, South Africa, Overall Revenue (2004-2018) 113

8.3 Hepatitis Viruses In South Africa 115

8.3.1 Hepatitis Viruses, South Africa, Overall Revenue (2004-2018) 115

8.4 Other Virology In South Africa 117

8.4.1 Other Virology, South Africa, Overall Revenue (2004-2018) 117

8.5 Bacteriology In South Africa 119

8.5.1 Bacteriology, South Africa, Overall Revenue (2004-2018) 119

8.6 Infectious Immunology Rapid Tests In South Africa 121

8.6.1 Infectious Immunology Rapid Tests, South Africa, Overall Revenue (2004-2018) 121

8.7 Infectious Immunology, South Africa, Distribution Share (2010-2011) 125

8.8 Infectious Immunology, South Africa, Company Share (2010-2011) 126

9 Overview of Key Companies in BRICS Infectious Immunology Market 128

9.1 Abbott Laboratories 128

9.1.1 Company Overview 128

9.1.2 Share in the BRICS Infectious Immunology Market 129

9.2 F. Hoffmann-La Roche Ltd. 130

9.2.1 Company Overview 130

9.2.2 Share in the BRICS Infectious Immunology Market 131

9.3 Shanghai Kehua Bio-engineering Co., Ltd. 132

9.3.1 Company Overview 132

9.3.2 Share in the BRICS Infectious Immunology Market 132

9.4 Siemens Healthcare 133

9.4.1 Company Overview 133

9.4.2 Share in the BRICS Infectious Immunology Market 134

9.5 bioMerieux S.A. 135

9.5.1 Company Overview 135

9.5.2 Share in the BRICS Infectious Immunology Market 136

9.6 DiaSorin S.p.A 137

9.6.1 Company Overview 137

9.6.2 Share in the BRICS Infectious Immunology Market 138

9.7 Qiagen N.V. 139

9.7.1 Company Overview 139

9.7.2 Share in the BRICS Infectious Immunology Market 140

9.8 Transasia Bio-Medicals Ltd. 141

9.8.1 Company Overview 141

9.8.2 Share in the BRICS Infectious Immunology Market 141

9.9 Alere Inc. 142

9.9.1 Company Overview 142

9.9.2 Share in the BRICS Infectious Immunology Market 143

9.10 Beckman Coulter, Inc. 144

9.10.1 Company Overview 144

9.10.2 Share in the BRICS Infectious Immunology Market 145

9.11 Gen-Probe Incorporated 146

9.11.1 Company Overview 146

9.11.2 Share in the BRICS Infectious Immunology Market 147

9.12 Becton, Dickinson and Company 148

9.12.1 Company Overview 148

9.12.2 Share in the BRICS Infectious Immunology Market 149

9.13 Bio-Rad Laboratories, Inc. 150

9.13.1 Company Overview 150

9.13.2 Share in the BRICS Infectious Immunology Market 151

9.14 PerkinElmer, Inc. 152

9.14.1 Company Overview 152

9.14.2 Share in the BRICS Infectious Immunology Market 153

9.15 Trivitron Healthcare Pvt Ltd. 154

9.15.1 Company Overview 154

9.15.2 Share in the BRICS Infectious Immunology Market 154

9.16 Span Diagnostics Ltd. 155

9.16.1 Company Overview 155

9.16.2 Share in the BRICS Infectious Immunology Market 155

9.17 Thermo Fisher Scientific Inc. 156

9.17.1 Company Overview 156

9.17.2 Share in the BRICS Infectious Immunology Market 157

9.18 Tulip Diagnostics (P) Ltd 158

9.18.1 Company Overview 158

9.18.2 Share in the BRICS Infectious Immunology Market 158

9.19 Cellestis Limited 159

9.19.1 Company Overview 159

9.19.2 Share in the BRICS Infectious Immunology Market 159

9.20 Chembio Diagnostics, Inc. 160

9.20.1 Company Overview 160

9.20.2 Share in the BRICS Infectious Immunology Market 160

9.21 Hologic, Inc. 161

9.21.1 Company Overview 161

9.21.2 Share in the BRICS Infectious Immunology Market 161

10 Appendix 162

10.1 Definitions of Markets Covered in the Report 163

10.1.1 Infectious Immunology 163

10.2 Research Methodology 164

10.3 Secondary Research 164

10.4 Primary Research 165

10.5 Models 165

10.6 Forecasts 166

10.7 Expert Panels 166

10.8 GlobalData Consulting 166

10.9 Currency Conversion 167

10.10 Contact Us 167

10.11 Disclaimer 167

List of Tables

Table 1: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16

Table 2: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18

Table 3: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20

Table 4: Infectious Immunology, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22

Table 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 24

Table 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 26

Table 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 28

Table 8: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29

Table 9: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30

Table 10: Other Virology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 31

Table 11: Other Virology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 32

Table 12: Retroviruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 33

Table 13: Retroviruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 34

Table 14: Bacteriology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 35

Table 15: Bacteriology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 36

Table 16: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 38

Table 17: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 40

Table 18: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 41

Table 19: Infectious Immunology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 43

Table 20: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 45

Table 21: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 47

Table 22: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 49

Table 23: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 50

Table 24: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 51

Table 25: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 52

Table 26: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 53

Table 27: Other Virology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54

Table 28: Other Virology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55

Table 29: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 56

Table 30: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 57

Table 31: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 59

Table 32: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 61

Table 33: Infectious Immunology, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 62

Table 34: Infectious Immunology, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 64

Table 35: Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 66

Table 36: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68

Table 37: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70

Table 38: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 72

Table 39: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 74

Table 40: Hepatitis Viruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 75

Table 41: Hepatitis Viruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 76

Table 42: Retroviruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 77

Table 43: Retroviruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 78

Table 44: Bacteriology, India, Revenue ($m), USD Constant, Historic, 2004-2011 79

Table 45: Bacteriology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 80

Table 46: Other Virology, India, Revenue ($m), USD Constant, Historic, 2004-2011 81

Table 47: Other Virology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82

Table 48: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 83

Table 49: Infectious Immunology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 85

Table 50: Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 87

Table 51: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 89

Table 52: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 91

Table 53: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92

Table 54: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93

Table 55: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94

Table 56: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95

Table 57: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96

Table 58: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97

Table 59: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98

Table 60: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99

Table 61: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 101

Table 62: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 103

Table 63: Infectious Immunology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 104

Table 64: Infectious Immunology, China, Company Share by Revenue ($m), USD Constant, 2010-2011 106

Table 65: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 108

Table 66: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 110

Table 67: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 112

Table 68: Retroviruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 113

Table 69: Retroviruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 114

Table 70: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 115

Table 71: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 116

Table 72: Other Virology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 117

Table 73: Other Virology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 118

Table 74: Bacteriology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 119

Table 75: Bacteriology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 120

Table 76: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 122

Table 77: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 124

Table 78: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 125

Table 79: Infectious Immunology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 127

Table 80: Abbott Laboratories, Revenue ($m), BRICS Infectious Immunology Market, 2011 129

Table 81: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 131

Table 82: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 132

Table 83: Siemens Healthcare, Revenue ($m), BRICS Infectious Immunology Market, 2011 134

Table 84: bioMerieux S.A., Revenue ($m), BRICS Infectious Immunology Market, 2011 136

Table 85: DiaSorin S.p.A, Revenue ($m), BRICS Infectious Immunology Market, 2011 138

Table 86: Qiagen N.V., Revenue ($m), BRICS Infectious Immunology Market, 2011 140

Table 87: Transasia Bio-Medicals Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 141

Table 88: Alere Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 143

Table 89: Beckman Coulter, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 145

Table 90: Gen-Probe Incorporated, Revenue ($m), BRICS Infectious Immunology Market, 2011 147

Table 91: Becton, Dickinson and Company, Revenue ($m), BRICS Infectious Immunology Market, 2011 149

Table 92: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 151

Table 93: PerkinElmer, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 153

Table 94: Trivitron Healthcare Pvt Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 154

Table 95: Span Diagnostics Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 155

Table 96: Thermo Fisher Scientific Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 157

Table 97: Tulip Diagnostics (P) Ltd, Revenue ($m), BRICS Infectious Immunology Market, 2011 158

Table 98: Cellestis Limited, Revenue ($m), BRICS Infectious Immunology Market, 2011 159

Table 99: Hologic, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 160

Table 100: Hologic, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 161

List of Figures

Figure 1: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15

Figure 2: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17

Figure 3: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19

Figure 4: Infectious Immunology, BRICS, Company share (%), 2011 21

Figure 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23

Figure 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25

Figure 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27

Figure 8: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29

Figure 9: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30

Figure 10: Other Virology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 31

Figure 11: Other Virology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 32

Figure 12: Retroviruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 33

Figure 13: Retroviruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 34

Figure 14: Bacteriology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 35

Figure 15: Bacteriology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 36

Figure 16: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 37

Figure 17: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 39

Figure 18: Infectious Immunology, Brazil, Company Share (%), 2011 42

Figure 19: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 44

Figure 20: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 46

Figure 21: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 48

Figure 22: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 50

Figure 23: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 51

Figure 24: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 52

Figure 25: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 53

Figure 26: Other Virology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54

Figure 27: Other Virology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55

Figure 28: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 56

Figure 29: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 57

Figure 30: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 58

Figure 31: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 60

Figure 32: Infectious Immunology, Russian Federation, Company Share (%), 2011 63

Figure 33: Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 65

Figure 34: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67

Figure 35: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69

Figure 36: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 71

Figure 37: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 73

Figure 38: Hepatitis Viruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 75

Figure 39: Hepatitis Viruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 76

Figure 40: Retroviruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 77

Figure 41: Retroviruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 78

Figure 42: Bacteriology, India, Revenue ($m), USD Constant, Historic, 2004-2011 79

Figure 43: Bacteriology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 80

Figure 44: Other Virology, India, Revenue ($m), USD Constant, Historic, 2004-2011 81

Figure 45: Other Virology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82

Figure 46: Infectious Immunology, India, Company Share (%), 2011 84

Figure 47: Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 86

Figure 48: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 88

Figure 49: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 90

Figure 50: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92

Figure 51: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93

Figure 52: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94

Figure 53: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95

Figure 54: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96

Figure 55: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97

Figure 56: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98

Figure 57: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99

Figure 58: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 100

Figure 59: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 102

Figure 60: Infectious Immunology, China, Company Share (%), 2011 105

Figure 61: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107

Figure 62: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 109

Figure 63: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 111

Figure 64: Retroviruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 113

Figure 65: Retroviruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 114

Figure 66: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 115

Figure 67: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 116

Figure 68: Other Virology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 117

Figure 69: Other Virology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 118

Figure 70: Bacteriology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 119

Figure 71: Bacteriology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 120

Figure 72: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 121

Figure 73: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 123

Figure 74: Infectious Immunology, South Africa, Company Share (%), 2011 126

Figure 75: Abbott Laboratories, Company Share (%), BRICS Infectious Immunology Market, 2011 129

Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Infectious Immunology Market, 2011 131

Figure 77: Siemens Healthcare, Company Share (%), BRICS Infectious Immunology Market, 2011 134

Figure 78: bioMerieux S.A., Company Share (%), BRICS Infectious Immunology Market, 2011 136

Figure 79: DiaSorin S.p.A, Company Share (%), BRICS Infectious Immunology Market, 2011 138

Figure 80: Qiagen N.V., Company Share (%), BRICS Infectious Immunology Market, 2011 140

Figure 81: Alere Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 143

Figure 82: Beckman Coulter, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 145

Figure 83: Gen-Probe Incorporated, Company Share (%), BRICS Infectious Immunology Market, 2011 147

Figure 84: Becton, Dickinson and Company, Company Share (%), BRICS Infectious Immunology Market, 2011 149

Figure 85: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 151

Figure 86: PerkinElmer, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 153

Figure 87: Thermo Fisher Scientific Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 157

Companies Mentioned

Abbott Laboratories

F. Hoffmann-La Roche Ltd.

Shanghai Kehua Bio-engineering Co., Ltd.

Siemens Healthcare

bioMerieux S.A.

DiaSorin S.p.A

Qiagen N.V.

Transasia Bio-Medicals Ltd.

Alere Inc.

Beckman Coulter, Inc.

Gen-Probe Incorporated

Becton, Dic

To order this report: General_Medicine_and_Specialty_Medicine Industry: Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker